One study shows that people on Mounjaro (tirzepatide), a dual GLP and GIP agonist, lost up to 22.5% of their body weight during the 72-week treatment when combined with diet and exercise
This Fella Health review takes an editorial look at the business model behind men-focused GLP-1 telehealth: how the service is built, how it makes money, and what trade-offs come with the design
[6] [16] For liraglutide (Saxenda), criteria include a BMI of 35 kg/m or above (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity
What About Non-HIV Populations
Jump to: How to time your medications | Does Wegovy affect levothyroxine absorption
Your provider will determine the most appropriate treatment options based on current medical guidelines, clinical evidence, and your individual health profile